XML 69 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Shareholders' equity (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of changes in share capital

Premiums

related to

Number of

Date

    

Nature of the transactions

    

Share capital

    

share capital

    

shares

    

Nominal value

(in euros)

Balance as of 31 December 2021

408,735

165,071,565

40,873,551

0.01

June 15, 2022

Capital increase by issue of ordinary shares - (ATM)

12,606

9,353,504

1,260,618

0.01

June 15, 2022

 

Transaction costs related to ATM

 

 

(539,404)

 

 

 

Balance as of 31 December 2022

 

421,341

 

173,885,665

 

42,134,169

 

0.01

August 30, 2023

 

August 2023 Share Issuance

 

96,186

 

30,491,082

 

9,618,638

 

0.01

August 30, 2023

 

Transaction costs related to the capital increase

 

 

(2,510,855)

 

 

December 8, 2023

 

Vesting of bonus shares

 

3,630

 

(3,630)

 

363,000

 

0.01

 

Balance as of 31 December 2023

 

521,158

 

201,862,263

 

52,115,807

 

0.01

March 25, 2024

 

AGA 2021 2021-BIS

 

3,614

 

(3,614)

 

361,381

 

0.01

October 17, 2024

 

Structured Financing (T1 New Shares and T1 BSAs)

 

346,005

 

38,422,366

 

34,600,507

 

0.01

December 16, 2024

 

AGA 2023-2

 

7,126

 

(7,126)

 

712,632

 

0.01

December 19, 2024

 

Structured Financing (T1 bis Shares and T1 bis BSAs) financing

 

78,721

 

8,885,708

 

7,872,064

 

0.01

 

Balance as of December 31, 2024

 

956,624

 

249,159,597

 

95,662,391

 

0.01

BSPCE Share Warrants  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

BSPCE 2021

 

Decision of issuance by the Board of Directors

 

04/16/2021

Grant date

 

04/16/2021

Beneficiary

 

Chief Executive Officer and Deputy Chief Officer (Frédéric Cren and Pierre Broqua)

Number of BSPCE granted

 

600,000

Expiration date

 

03/31/2034

Number of shares per BSPCE

 

1

Subscription price (€)

0

Exercise price (€)

11.74

Performance condition

Partially

(1)

Valuation method used

Monte Carlo

Fair value at grant date (€)

[5.4 – 5.7]

(1)

Expected volatility

64

%

Average life (years)

5

Risk-free rate

0.60

%

Expected dividends

 

(1)The fair value at grant date is different depending on whether the BSPCEs are subject to market performance conditions.
BSA Share warrant  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

    

BSA

BSA

 

    

BSA 2017

    

2018-1

    

BSA 2019

    

2019 Bis

    

BSA 2019 ter

    

BSA 2021

 

BSA 2023

    

BSA 2023-2

Decision of issuance by the Board of Directors

05/29/2017

12/14/2018

 

06/28/2019

 

03/09/2020

 

03/09/2020

04/16/2021

05/25/2023

12/15/2023

Grant date

05/29/2017

12/14/2018

 

06/28/2019

 

03/09/2020

 

03/09/2020

04/16/2021

05/25/2023

12/15/2023

Beneficiary

Directors

Service providers

 

Service providers

 

Service providers

 

Service providers

Service providers

Service providers

Service providers

Vesting period (year)

3 tranches: 1 year, 2 years and 3 years

between 1 and 3 years

 

1

 

1

 

between 1 and 3 years

3

2.9 years

2.3 years

Expiration date

05/29/2027

12/14/2028

 

06/28/2029

 

03/09/2030

 

03/09/2030

03/31/2034

03/31/2036

03/31/2036

Number of BSA granted

195,000

126,000

 

10,000

 

10,000

 

36,000

50,000

10,000

20,000

Number of shares per BSA

1

1

 

1

 

1

 

1

1

1

1

Subscription premium price per share (€)

0.534

0.48

 

0.18

 

0.29

 

0.29

2.45

0.20

0.31

Exercise price per share (€)

6.675

6.067

 

2.20

 

3.68

 

3.68

11.74

2.51

3.91

Performance condition

No

No

 

No

 

No

 

No

Yes

No

No

Valuation method

Black and Scholes

Black and Scholes

Black and Scholes

Black and Scholes

Black and Scholes

Monte Carlo

Black and Scholes

Black and Scholes

Fair value per BSA at grant date (€)

2.47

1.98

0.48

0.90

0.90

[3.03.2]

(1)

1.89

2.67

Expected volatility

40

%

40

%

40

%

40

%

40

%

64

%

65

%

62

%

Average life (years)

6

6

5.5

6

6

5

6.5

6.2

Risk free rate

0.22

%

0.30

%

0.33

%

0.0

%

0.0

%

0.60

%

2.96

%

2.65

%

Expected dividends

 

 

 

(1)The fair value at grant date is different depending on whether the BSAs are subject to market performance conditions.
BSPCE and BSA Share Warrants  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

    

Exercise

    

Outstanding

    

    

    

    

Outstanding

    

Number of

price

at Jan 1,

Forfeited /

at December 31,

exercisable

Type

    

Grant Date

    

(in euros)

    

2024

    

Issued

    

Exercised

    

Lapsed

    

2024

    

shares

BSPCE - Plan 2021

04/16/2021

11.74

430,000

430,000

430,000

TOTAL BSPCE share warrants

 

  

 

  

 

430,000

 

 

 

 

430,000

 

430,000

BSA - Plan 2017

 

05/29/2017

 

6.67

 

130,000

 

 

 

 

130,000

 

130,000

BSA - Plan 2018

 

12/14/2018

 

6.07

 

116,000

 

 

 

 

116,000

 

116,000

BSA 2019

 

06/28/2019

 

2.20

 

10,000

 

 

 

 

10,000

 

10,000

BSA 2019 bis

03/09/2020

3.68

10,000

10,000

10,000

BSA 2019 ter

03/09/2020

3.68

36,000

36,000

36,000

BSA 2021

04/16/2021

11.74

14,333

14,333

14,333

BSA 2023

05/25/2023

2.51

10,000

10,000

BSA 2023 - 2

12/15/2023

3.91

20,000

20,000

TOTAL BSA share warrants

 

  

 

  

 

346,333

 

 

 

 

346,333

 

316,333

Total share warrants

 

776,333

 

 

 

 

776,333

 

746,333

    

    

Exercise

    

Outstanding

    

    

    

    

Outstanding

    

Number of

price

at Jan 1,

Forfeited /

at December 31,

exercisable

Type

Grant Date

    

(in euros)

    

2023

    

Issued

    

Exercised

    

Lapsed

    

2023

    

shares

BSPCE - Plan 2013

12/13/2013

 

0.59

 

8,800

 

 

 

(8,800)

 

 

BSPCE - Plan 2021

04/16/2021

 

11.74

 

480,000

 

 

 

(50,000)

 

430,000

 

430,000

TOTAL BSPCE share warrants

  

 

  

 

488,800

 

 

 

(58,800)

 

430,000

 

430,000

BSA - Plan 2017

05/29/2017

 

6.67

 

130,000

 

 

 

 

130,000

 

130,000

BSA - Plan 2018

12/14/2018

 

6.07

 

116,000

 

 

 

 

116,000

 

116,000

BSA 2019

06/28/2019

2.20

10,000

10,000

10,000

BSA 2019 bis

03/09/2020

3.68

10,000

10,000

10,000

BSA 2019 ter

03/09/2020

 

3.68

 

36,000

 

 

 

 

36,000

 

36,000

BSA 2021

04/16/2021

 

11.74

 

16,000

 

 

 

(1,667)

 

14,333

 

BSA 2023

05/25/2023

2.51

10,000

10,000

BSA 2023 - 2

12/15/2023

3.91

20,000

20,000

TOTAL BSA share warrants

  

318,000

30,000

(1,667)

346,333

302,000

Total share warrants

806,800

30,000

(60,467)

776,333

732,000

    

    

Exercise

    

Outstanding

    

    

    

    

Outstanding

    

Number of

price

at January 1,

at December 31,

shares

Type

    

Grant date

    

(in euros)

    

2022

    

Issued

    

Exercised

    

Forfeited

    

2022

    

exercisable

BSPCE — 2013 plan

Dec. 13, 2013

 

0.59

 

8,800

 

 

 

 

8,800

 

8,800

BSPCE Plan 2021

April 16, 2021

11.74

600,000

(120,000)

480,000

Total BSPCE

 

 

608,800

 

 

 

(120,000)

 

488,800

 

8,800

BSA — 2017 plan

May 29, 2017

 

6.67

 

130,000

 

 

 

 

130,000

 

130,000

BSA — 2018 plan

Dec. 14, 2018

 

6.07

 

116,000

 

 

 

 

116,000

 

116,000

BSA — 2019 plan

June 28, 2019

 

2.20

 

10,000

 

 

 

 

10,000

 

10,000

BSA 2019 Bis

March 9, 2020

3.68

10,000

10,000

10,000

BSA 2019 Ter

March 9, 2020

 

3.68

 

36,000

 

 

 

 

36,000

 

24,000

BSA – Plan 2021-1

April 16, 2021

11.74

20,000

(4,000)

16,000

Total BSA

 

322,000

 

 

 

(4,000)

 

318,000

 

290,000

Total

930,800

(124,000)

806,800

298,800

AGA Bonus Share Award Plan  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

AGA 2021

    

AGA 2021-bis

    

AGA 2023

    

AGA 2023-2

Decision of issuance by the Board of Directors

 

04/16/2021

 

12/08/2021

05/25/2023

12/15/2023

Grant date

 

04/16/2021

 

12/08/2021

05/25/2023

12/15/2023

Beneficiary

 

Employees

 

Employees

Deputy Chief Executive Officer (Pierre Broqua)

Employees

Vesting period (year)

 

3

 

3

4

1

Holding period (year)

 

 

4

1

Service condition

 

Yes

 

Yes

Yes

Yes

Performance condition

 

Partially

(1)

Partially

(1)

No

No

Number of AGA granted

 

466,000

 

123,000

300,000

760,000

Number of shares per AGA

 

1

 

1

1

1

Valuation method used

Dual

(1)

Dual

(1)

Dual

(1)

Dual

(1)

Fair value per AGA at grant date

[9.8 – 11.3]

(1)

[11.4 – 12.2]

(1)

2.60

3.9

Expected volatility

64

%

64

%

N/A

N/A

Average life (years)

3

2.3

N/A

N/A

Risk-free rate

0.60

%

0.60

%

N/A

N/A

Expected dividends

Stock price reference

N/A

N/A

N/A

N/A

Non-transferable discount

 

N/A

 

N/A

N/A

N/A

    

AGA 2024-1

    

AGA 2024-2

    

AGA 2024-3

    

AGA 2024-4

 

(Tr1 - Tr2 - Tr3)

(Tr1 - Tr2 - Tr3)

(Tr1 - Tr2 - Tr3)

(Tr1 - Tr2 - Tr3)

 

Decision of issuance by the Board of Directors

 

12/13/2024

12/13/2024

12/13/2024

12/13/2024

Grant date

 

01/06/2025

01/06/2025

01/06/2025

01/17/2025

Beneficiary

 

Chief Executive Officer (Frédéric Cren)

Deputy Chief Executive Officer (Pierre Broqua)

Employees

Employees

Vesting period (year)

 

3

3

3

3

Holding period (year)

 

1

1

1

1

Service condition

 

Yes

Yes

Yes

Yes

Performance condition

 

Yes

Yes

No

No

Number of AGA granted

 

800,000

800,000

1,577,000

113,000

Number of shares per AGA

 

1

1

1

1

Valuation method used

 

Dual

(1)

Dual

(1)

Dual

(1)

Dual

(1)

Fair value per AGA at grant date

 

2,3

2,3

2,3

2,3

Expected volatility

 

N/A

N/A

N/A

N/A

Average life (years)

 

N/A

N/A

N/A

N/A

Risk-free rate

 

N/A

N/A

N/A

N/A

Expected dividends

 

Stock price reference

 

N/A

N/A

N/A

N/A

Non-transferable discount

 

N/A

N/A

N/A

N/A

(1)AGA 2021-1 and AGA 2021-bis plans are partially composed of AGAs subject to a market performance condition. AGAs 2023-1, AGAs 2023-2, AGA 2024-1, AGA 2024-2, AGA 2024-3 and AGA 2024-4 are not subject to a market performance condition. Accordingly, AGAs not subject to performance conditions are valued on the basis of the share price less future dividends, discounted at the risk-free rate. AGAs subject to performance conditions are valued using the same method, adjusted by a discount applied to reflect the performance condition. This discount is determined using the “Monte Carlo” analysis. The fair value at the grant date is different depending on whether the AGAs are subject to market performance conditions.
Bonus share award plans  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

Stock price

Outstanding

Outstanding

at grant date

at Jan 1,

Forfeited /

at December 31,

Type

    

Grant Date

    

(in euros)

    

2024

    

Granted

    

Vested

    

Lapsed

    

2024

AGA - Plan 2021 - 1

04/16/2021

11.30

297,599

(296,166)

(1,433)

AGA - Plan 2021 - bis

12/08/2021

12.20

65,215

(65,215)

AGA 2023-1

05/25/2023

2.60

300,000

300,000

(75,000)

525,000

AGA 2023-2

12/15/2023

3.90

748,000

(712,632)

(35,368)

TOTAL free shares

1,410,814

300,000

(1,074,013)

(111,801)

525,000

Stock price

Outstanding 

 at grant

Outstanding

at

date

 at Jan 1,

Forfeited /

December 31,

Type

    

Grant Date

    

 (in euros)

    

2023

    

Granted

    

Vested

    

 Lapsed

    

 2023

AGA - Plan 2021 - 1

04/16/2021

11.30

340,800

(43,201)

297,599

AGA - Plan 2021 - bis

12/08/2021

12.20

76,800

(11,585)

65,215

AGA 2022

12/08/2022

4.18

373,000

(363,000)

(10,000)

AGA 2023-1

05/25/2023

2.60

300,000

300,000

AGA 2023-2

12/15/2023

3.90

760,000

(12,000)

748,000

TOTAL free shares

 

 

 

790,600

 

1,060,000

 

(363,000)

 

(76,786)

 

1,410,814

Stock price

Outstanding

at grant

Outstanding

at

date

at January 1,

Forfeited /

December 31,

Type

    

Grant date

    

(in euros)

    

2022

    

Issued

    

Vested

    

Lapsed

    

2022

AGA — 2021-1 plan

04/16/21

 

11.30

 

448,000

 

 

 

(107,200)

 

340,800

AGA —2021-bis plan

12/08/21

 

12.20

 

123,000

 

 

 

(46,200)

 

76,800

AGA —2022 plan

12/08/22

 

4.18

 

 

373,000

 

 

 

373,000

Total AGA

  

 

  

 

571,000

 

373,000

 

 

(153,400)

 

790,600

Reference

Outstanding

Outstanding

Number of

price

at Jan 1,

Convert

at December 31,

exercisable

Type

    

Grant Date

    

(in euros)

    

2023

    

Issued

    

Exercised

    

AGA

    

2023

    

shares

PAGUP 2023

05/25/2023

 

2.60

 

 

300,000

 

 

 

300,000

 

TOTAL PAGUP

 

 

300,000

 

 

 

300,000

 

Reference 

Outstanding 

Number of 

price 

Outstanding 

Convert 

at December 

exercisable 

Type

    

Grant Date

    

(in euros)

    

at Jan 1, 2024

    

Issued

    

Exercised

    

AGA

    

31, 2024

    

shares

PAGUP 2023

 

05/25/2023

 

2.60

 

300,000

 

 

 

(300,000)

 

 

TOTAL AGA

 

300,000

 

 

 

(300,000)

 

 

Stock options plans  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of movements in BSPCE and BSA share warrants and Bonus shares

    

SO 2024-1

    

SO 2024-2

Decision of issuance by the Board of Directors

 

12/20/2024

 

12/20/2024

Grant date

 

01/23/2025

 

01/23/2025

Beneficiary

 

Chairman since
12/13/2024
(Mark
Pruzanski)

 

non-French
Employees

Vesting period (year)

 

3

 

3

Holding period (year)

 

1

 

1

Service condition

 

Yes

 

Yes

Performance condition

 

Yes

 

No

Number of SO granted

 

12,898,116

 

301,000

Number of shares per SO

 

1

 

1